Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

NCT06117280 is registered in ClinicalTrials.gov with Iovate Health Sciences International Inc as lead sponsor.

NCT NCT06117280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06117280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Lead sponsor
Iovate Health Sciences International Inc
Phase
Not applicable
Overall status
Completed
Start date
July 18, 2023
Completion date
October 20, 2023
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caffeine withdrawal, energy, focus